Tissue adhesives for peripheral intravenous catheter securement: A prospective randomized controlled pilot trial.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
06 2021
Historique:
received: 24 10 2020
revised: 25 01 2021
accepted: 28 01 2021
pubmed: 21 2 2021
medline: 22 6 2021
entrez: 20 2 2021
Statut: ppublish

Résumé

In some patients securing the peripheral intravenous cannula (PIVC) with a standard adhesive dressing can be difficult because of sweat or other body fluids. The aim of our study was to evaluate the use of tissue adhesives alone as a means to secure PIVCs inserted in the emergency department. We performed a prospective interventional pilot study from November 2019 to May 2020 in a medical emergency department of an urban tertiary hospital. Patients were randomized to two groups: tissue adhesives (TA) or adhesive dressing (AD) group. After randomization we followed them until day 4. There were no significant differences between TA and AD groups in the rate of unplanned removal of PIVCs in the first 72 h (57.1% vs. 45.8%, p = 0.29), the rate of unplanned removal of PIVCs in the ED (0% vs. 2.1%, p = 1.00), the rate of unplanned removal of PIVC in the first 24 h (42.8% vs. 35.4%, p = 0.52), as well as in the rate of phlebitis (7.1% vs. 14.6%, p = 0.34) and the rate of any blood-stream infection (0% vs. 0%, p = 1.00). We did not observe any significant differences when PIVCs inserted in the emergency department were secured with tissue adhesives alone, compared to standard adhesive dressings. We observed a high rate of unplanned removal of PIVCs, necessitating further research to determine more reliable ways of securing PIVCs.

Sections du résumé

BACKGROUND
In some patients securing the peripheral intravenous cannula (PIVC) with a standard adhesive dressing can be difficult because of sweat or other body fluids. The aim of our study was to evaluate the use of tissue adhesives alone as a means to secure PIVCs inserted in the emergency department.
METHODS
We performed a prospective interventional pilot study from November 2019 to May 2020 in a medical emergency department of an urban tertiary hospital. Patients were randomized to two groups: tissue adhesives (TA) or adhesive dressing (AD) group. After randomization we followed them until day 4.
RESULTS
There were no significant differences between TA and AD groups in the rate of unplanned removal of PIVCs in the first 72 h (57.1% vs. 45.8%, p = 0.29), the rate of unplanned removal of PIVCs in the ED (0% vs. 2.1%, p = 1.00), the rate of unplanned removal of PIVC in the first 24 h (42.8% vs. 35.4%, p = 0.52), as well as in the rate of phlebitis (7.1% vs. 14.6%, p = 0.34) and the rate of any blood-stream infection (0% vs. 0%, p = 1.00).
CONCLUSION
We did not observe any significant differences when PIVCs inserted in the emergency department were secured with tissue adhesives alone, compared to standard adhesive dressings. We observed a high rate of unplanned removal of PIVCs, necessitating further research to determine more reliable ways of securing PIVCs.

Identifiants

pubmed: 33610080
pii: S0735-6757(21)00099-1
doi: 10.1016/j.ajem.2021.01.088
pii:
doi:

Substances chimiques

Tissue Adhesives 0

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

128-131

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors declare that there are no conflict of interests relating to the study entitled “Tissue Adhesives for Peripheral Intravenous Catheter Securement: a Propective Randomized Controlled Pilot Trial.”

Auteurs

Amadeus Lešnik (A)

Medical Emergency Department, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia.

Mario Gorenjak (M)

Centre for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Taborska ulica 8, Maribor 2000, Slovenia.

Sandi Žumer (S)

Medical Emergency Department, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia.

Valerija Zorčič (V)

Medical Emergency Department, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia.

Žarko Mišanović (Ž)

Medical Emergency Department, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia.

Marko Majhenič (M)

Medical Emergency Department, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia.

Anja Podstenšek (A)

Medical Emergency Department, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia.

Matevž Toplak (M)

Medical Emergency Department, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia.

Urška Fekonja (U)

Medical Emergency Department, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia.

Andrej Markota (A)

Medical Intensive Care Unit, University Medical Centre Maribor, Ljubljanska 5, Maribor 2000, Slovenia; Faculty of Medicine, University of Maribor, Taborska ulica 8, Maribor 2000, Slovenia. Electronic address: andrejmarkota@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH